日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FAM49B suppresses ovarian cancer cell growth through regulating MAPK signaling.

FAM49B 通过调节 MAPK 信号通路抑制卵巢癌细胞生长。

Yue Chen, Zhou Dong, Zhou Yuzhao, Feng Qidong, Fang Kun, Meng Songshu, Yu Weiting, Du Sha, Shen Dachuan, Wang Yifei

Skills in handling Turbuhaler, Diskus in the west of China

中国西部地区熟练使用都保吸入器和迪斯库斯吸入器

Wei, Wei; Wang, Dong; Liu, Weiting; Du, Hui; Zhang, Zhiye; Che, Shengying; Ding, Rui; Yang, YanBiao

Development of Quantitative Methylation-Specific Droplet Digital PCR (ddMSP) for Assessment of Natural Tregs

开发定量甲基化特异性液滴数字 PCR (ddMSP) 用于评估天然 Treg

Mohamed I Husseiny, Ahmed Fahmy, Weiting Du, Angel Gu, Pablo Garcia, Kevin Ferreri, Fouad Kandeel

Intra-pancreatic tissue-derived mesenchymal stromal cells: a promising therapeutic potential with anti-inflammatory and pro-angiogenic profiles

胰腺内组织来源的间充质基质细胞:具有抗炎和促血管生成特性的有希望的治疗潜力

Bashar Khiatah, Meirigeng Qi, Weiting Du, Kuan T-Chen, Kayleigh M van Megen, Rachel G Perez, Jeffrey S Isenberg, Fouad Kandeel, Bart O Roep, Hsun Teresa Ku, Ismail H Al-Abdullah

Foxp3+ Treg expanded from patients with established diabetes reduce Helios expression while retaining normal function compared to healthy individuals

与健康个体相比,从患有糖尿病的患者中扩增出的 Foxp3+ Treg 可降低 Helios 表达,同时保持正常功能

Weiting Du, Yueh-Wei Shen, Wen-Hui Lee, Ding Wang, Sachiko Paz, Fouad Kandeel, Chih-Pin Liu

Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells

抑制 S 期激酶相关蛋白 2 (Skp2) 可重新编程糖尿病性 T 细胞并将其转化为 Foxp3+ 调节性 T 细胞

Ding Wang, Hanjun Qin, Weiting Du, Yueh-Wei Shen, Wen-Hui Lee, Arthur D Riggs, Chih-Pin Liu

Killer cell Ig-like receptor (KIR) 3DL1 down-regulation enhances inhibition of type 1 diabetes by autoantigen-specific regulatory T cells

杀伤细胞免疫球蛋白样受体 (KIR) 3DL1 下调增强自身抗原特异性调节性 T 细胞对 1 型糖尿病的抑制

Hanjun Qin, Zunde Wang, Weiting Du, Wen-Hui Lee, Xiwei Wu, Arthur D Riggs, Chih-Pin Liu